What is Alto Neuroscience's PP&E (net)?

Alto Neuroscience (ANRO) reported PP&E (net) of $2.23M in Q1 2026.

How has Alto Neuroscience's PP&E (net) changed year-over-year?

Alto Neuroscience's PP&E (net) decreased by 9.8% year-over-year, from $2.48M to $2.23M.

What is the long-term trend for Alto Neuroscience's PP&E (net)?

Over 2 years (2023 to 2025), Alto Neuroscience's PP&E (net) has grown at a 30.1% compound annual growth rate (CAGR), from $1.11M to $1.87M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Alto Neuroscience ANRO PP&E (Net)

PP&E (Net) at other companies

Xenon PharmaceuticalsXENE

$8.29M-14.5%

Acadia PharmaceuticalsACAD

$14.65M+319%

Rapport Therapeutics, Inc.RAPP

$2.52M-26.0%

Praxis Precision Medicines, Inc.PRAX

$170K-31.2%

MeiraGTx Holdings plcMGTX

$102.57M-1.8%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$1.53M—

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$874.19M+1,358%

Enterprise value$630.81M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's PP&E (net)?: Alto Neuroscience (ANRO) reported PP&E (net) of $2.23M in Q1 2026.
How has Alto Neuroscience's PP&E (net) changed year-over-year?: Alto Neuroscience's PP&E (net) decreased by 9.8% year-over-year, from $2.48M to $2.23M.
What is the long-term trend for Alto Neuroscience's PP&E (net)?: Over 2 years (2023 to 2025), Alto Neuroscience's PP&E (net) has grown at a 30.1% compound annual growth rate (CAGR), from $1.11M to $1.87M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.